Loading news article.

Newsbenzinga

Regeneron Pharmaceuticals Q3 2026 Earnings Call Transcript

Oct 30, 2026, 09:42 ET · Published

Article summary

Regeneron Pharmaceuticals (NASDAQ:REGN) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by

An excerpt from the original article.

Related companies

REGNREGNView stock

Repost

Comments —

Loading comments…